Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2002 1
2003 2
2004 5
2006 1
2007 1
2008 2
2009 2
2010 6
2011 1
2012 4
2013 4
2014 2
2015 1
2017 2
2019 3
2020 3
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Small molecule inhibitors of BRAF in clinical trials.
Zambon A, Niculescu-Duvaz I, Niculescu-Duvaz D, Marais R, Springer CJ. Zambon A, et al. Among authors: niculescu duvaz d. Bioorg Med Chem Lett. 2012 Jan 15;22(2):789-92. doi: 10.1016/j.bmcl.2011.11.060. Epub 2011 Dec 3. Bioorg Med Chem Lett. 2012. PMID: 22222036 Review.
BRAF as a therapeutic target: a patent review (2006 - 2012).
Zambon A, Niculescu-Duvaz D, Niculescu-Duvaz I, Marais R, Springer CJ. Zambon A, et al. Among authors: niculescu duvaz d. Expert Opin Ther Pat. 2013 Feb;23(2):155-64. doi: 10.1517/13543776.2013.741593. Epub 2013 Jan 7. Expert Opin Ther Pat. 2013. PMID: 23294221 Review.
The EGF receptor Hokey-Cokey.
Niculescu-Duvaz D, Whittaker S, Springer C, Marais R. Niculescu-Duvaz D, et al. Cancer Cell. 2007 Mar;11(3):209-11. doi: 10.1016/j.ccr.2007.02.021. Cancer Cell. 2007. PMID: 17349577 Free article.
Design of prodrugs for suicide gene therapy.
Niculescu-Duvaz D, Niculescu-Duvaz I, Springer CJ. Niculescu-Duvaz D, et al. Methods Mol Med. 2004;90:161-202. doi: 10.1385/1-59259-429-8:161. Methods Mol Med. 2004. PMID: 14657564 Review. No abstract available.
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships.
Leung L, Niculescu-Duvaz D, Smithen D, Lopes F, Callens C, McLeary R, Saturno G, Davies L, Aljarah M, Brown M, Johnson L, Zambon A, Chambers T, Ménard D, Bayliss N, Knight R, Fish L, Lawrence R, Challinor M, Tang H, Marais R, Springer C. Leung L, et al. Among authors: niculescu duvaz d. J Med Chem. 2019 Jun 27;62(12):5863-5884. doi: 10.1021/acs.jmedchem.9b00335. Epub 2019 May 23. J Med Chem. 2019. PMID: 31070916 Free PMC article.
V599EB-RAF is an oncogene in melanocytes.
Wellbrock C, Ogilvie L, Hedley D, Karasarides M, Martin J, Niculescu-Duvaz D, Springer CJ, Marais R. Wellbrock C, et al. Among authors: niculescu duvaz d. Cancer Res. 2004 Apr 1;64(7):2338-42. doi: 10.1158/0008-5472.can-03-3433. Cancer Res. 2004. PMID: 15059882
Toward the Scale-Up of a Bicyclic Homopiperazine via Schmidt Rearrangement and Photochemical Oxaziridine Rearrangement in Continuous-Flow.
Brown M, Aljarah M, Asiki H, Leung LMH, Smithen DA, Miller N, Nemeth G, Davies L, Niculescu-Duvaz D, Zambon A, Springer C. Brown M, et al. Among authors: niculescu duvaz d. Org Process Res Dev. 2021 Jan 15;25(1):148-156. doi: 10.1021/acs.oprd.0c00361. Epub 2020 Oct 15. Org Process Res Dev. 2021. PMID: 33679122 Free PMC article.
2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth.
Smithen DA, Leung LMH, Challinor M, Lawrence R, Tang H, Niculescu-Duvaz D, Pearce SP, Mcleary R, Lopes F, Aljarah M, Brown M, Johnson L, Thomson G, Marais R, Springer C. Smithen DA, et al. Among authors: niculescu duvaz d. J Med Chem. 2020 Mar 12;63(5):2308-2324. doi: 10.1021/acs.jmedchem.9b01112. Epub 2019 Sep 4. J Med Chem. 2020. PMID: 31430136 Free PMC article.
38 results